Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, SBS

Fitango Health, Inc. Launched Today Ensemble - an API-based Patient Experience Platform


NEW YORK, Sept. 22, 2021 /PRNewswire/ -- Fitango Health today announced the launch of Fitango Ensemble, an innovative, first-to-the-market patient experience platform. ­­Ensemble's fully patent-pending, API-based technology is highly flexible, boasts rapid implementation, and integrates seamlessly with existing systems. The solution enables customized care planning to optimize the patient journey and reimagine the patient experience. 

Ensemble's virtual care platform allows clinicians to build and "prescribe" patients with a variety of digital therapies. The adaptability and versatility of the technology span multiple clinical service lines. It allows clinicians to monitor and measure adherence to prescribed therapies, improving patient experience, and health outcomes while reducing costs.

Fitango Ensemble offers a robust collection of integrated, API-based components. The technology enables organizations like health systems, EHR companies, and digital health companies to easily deliver an end-to-end patient experience solution for clinicians and their patients. The high degree of scalability of Ensemble's components allows for continuous adaptation to new organizational requirements. Fitango Ensemble's technology supports the virtualization of care and contributes a much-needed solution to the developing healthcare demand for tech-empowered clinicians and patient-centric experiences. 

Notable capabilities of the Ensemble platform include seven types of digital programs and therapies (e.g., recovery plans, adaptive assessments, educational materials, etc.), advanced family engagement, platform gamification, a motivation center, an advanced business rules engine, ML-based predictions, and more. The proposed infrastructure integrates easily with a variety of interfaces, adding value to existing workflows without complicated implementations or siloed tech solutions. The platform offers a robust library of APIs for integration with any of these elements and Ensemble's core four offerings: content management, active patient & family engagement, population health, and virtual care.

"We are proud to release our first-in-the-market, API-based complete patient experience platform. This enables our customers to quickly and easily revolutionize their patient experience, achieving improved satisfaction, outcomes, and lower costs," says Dr. Dov Biran, Founder, and CEO at Fitango Health. "The unique content builder capabilities enable organizations to implement solutions for any therapeutic area. Our goal is to empower clinicians in different areas so they can build and provide their patients with superior, measurable therapies."

Fitango Ensemble is available immediately. For more information on Fitango Ensemble, visit www.fitango.com 

About Fitango Health: Fitango Health, Inc. is a leading patient experience company reimagining healthcare delivery based on active patient engagement. By enabling clinicians to empower, educate, and engage patients in their health journey with innovative technology, Fitango Health helps their customers embrace digital transformation and stay on the cutting edge of care. 

Jessica Cobb
Fitango Health, Inc.
(845) 702-1449
[email protected] 

SOURCE Fitango Health


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: